About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Lupus Clinical Trials | 1,277 Studies Recruiting

Clinical TrialsLupus

Lupus Clinical Trials

Browse 1,277 clinical trials for lupus. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 1061-1080 of 1,277 trials

No longer availableIndividual Patient Expanded Access IND of Autologous HB-adMSCs for the Treatment of Systemic Lupus Erythematosus (SLE)This protocol is part of an FDA Individual Patient Expanded Access IND.NCT04907175·Sugar Land, Texas CompletedTacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous NephritisThe investigators study the efficacy and safety of tacrolimus in the treatment of membranous nephritis secondary to systemic lupus erythematosus.NCT00125307·Shatin Active not recruitingA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus ErythematosusThe goal of this clinical trial is to learn if VENT-03 works to treat patients with cutaneous lupus erythematosus (CLE) who may or may not have systemic lupus erythematosus (SLE).NCT07260877·Beverly Hills, California and 33 others

Related Searches

sletrials systemic lupustrials

Data from ClinicalTrials.govTerms

RecruitingAnti CD19/BCMA CAR Gene Therapy for Autoimmune DiseasesThis is an open label, single-site, dose-escalation study in up to 18 participants with treatment of Refractory Autoimmune Diseases.NCT07121777·Hefei, Anhui

UnknownAccuracy, Feasibility and Acceptance of CGM LupusThis is a prospective monocenter, non-randomised, open-lable single-group intervention diagnostic trial on the accuracy, reliability and feasibility of the continuous glucose…NCT03296995·Shanghai, Shanghai Municipality

Not yet recruitingFirst-in-Human Study of ISH0613: Safety, Tolerability, Pharmacokinetics, and PharmacodynamicsThe goal of this clinical trial is to learn about a study drug called ISH0613 and how it behaves in healthy adults.NCT07516639·Nanjing, Jiangsu

UnknownH-pylori Infection With Disease Activity in Systemic Lupus Erythematosus and Rheumatoid ArthritisTo find the relation of Helicobacter pylori with disease activity in SLE and RANCT06586567

UnknownLaser Puncture and Program of Lifestyle Modification in Lupus FemalesSerum lipid profile was significantly dysregulated in female systemic lupus erythematosus (SLE) patientsNCT05381545·Giza, Dokki

Not yet recruitingInducible Co-stimulator Gene With Systemic Lupus ErythematosusThe aim of this study is to investigate the association between ICOS gene polymorphism and susceptibility to systemic lupus erythematosus (SLE), as well as its impact on disease…NCT07675837·Qina

CompletedA Study of DS-7011a in Patients With Systemic Lupus ErythematosusSystemic lupus erythematosus (SLE) is a systemic chronic autoimmune disease characterized by autoantibody production, inflammation, and tissue damage in multiple organs.NCT05638802·Anniston, Alabama and 19 others

CompletedVitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)The purpose of this study is to test the safety and effectiveness of different doses of vitamin D in patients with Systemic Lupus Erythematosus (SLE).NCT00418587·Charleston, South Carolina

CompletedA Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and GenderA study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and repeat doses of 800 mg GSK2586184 in healthy subjects.NCT01687309·Antwerp

RecruitingImmune Profiling of Refractory cSLE Exposed to CD3×CD19 BiTEThis prospective observational study aims to characterize the peripheral immune landscape of pediatric patients with childhood-onset systemic lupus erythematosus ( cSLE) who are…NCT07352332·Hangzhou

RecruitingSubgrouping SLE - a New Approach to Understand the Pathogenesis and Improve TreatmentThe goal of this observational study is to investigate different phenotypes among patients with SLE and to compare with matched general population controls.NCT07102030·Stockholm

UnknownPractice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective StudyTreat to target (T2T) strategies have proved to be useful in several chronic disorders, including Rheumatoid Arthritis.NCT04942314

Not yet recruitingACE1831 in Adult Subjects With Relapsed/Refractory Systemic Lupus Erythematosus （SLE）ACE1831 is an off-the-shelf, allogeneic gamma delta T (gdT) cell therapy derived from healthy donors, that is under investigation for the treatment in subjects with…NCT07314567·Wuhan, Hubei

Active not recruitingLupus Education Alliance ProgramRandomized controlled trial of a COVID-19 behavioral and educational intervention for people with systemic lupus erythematosus (SLE).NCT05243875·New Orleans, Louisiana

RecruitingExploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Relapsed/Refractory Autoimmune DiseasesA single arm, open-label pilot study is designed to determine the safety and effectiveness of anti-CD19/BCMA U CAR T cells in patients with autoimmune diseases.NCT07246096·Shanghai

RecruitingSystemic Lupus Erythematosus Within the Framework of the Multidisciplinary ConsultationDiagnosis and follow up of a lupus cohort in a multidisciplinary consultation in Brest ( France)NCT04320680·Brest

CompletedEffectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus TreatmentThis project aims to improve adherence rate through pharmaceutical care in patients with systemic lupus erythematosus (SLE) to help achieving therapeutic goals and finally to…NCT02330250·Rio de Janeiro, Rio de Janeiro

PreviousPage 54 of 64Next